| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P6179 | Dimensions Publication ID | 1009267846 |
| P356 | DOI | 10.1245/S10434-016-5298-9 |
| P698 | PubMed publication ID | 27278203 |
| P2093 | author name string | Marina Yamada | |
| Satoshi Matsumoto | |||
| Eiji Uchida | |||
| Akihisa Matsuda | |||
| Masao Miyashita | |||
| Yoichi Kawano | |||
| Nobuyuki Sakurazawa | |||
| Suun Sathornviriyapong | |||
| P2860 | cites work | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement | Q21195843 |
| Epidemiology of esophageal cancer | Q24625927 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review | Q26777898 | ||
| WINPEPI updated: computer programs for epidemiologists, and their teaching potential | Q27498033 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma | Q32033905 | ||
| Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities | Q33612658 | ||
| Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma | Q33764809 | ||
| Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor. | Q33970074 | ||
| Oesophageal carcinoma | Q34325751 | ||
| Meta-analysis of postoperative efficacy in patients receiving chemoradiotherapy followed by surgery for resectable esophageal carcinoma | Q34469077 | ||
| Pulmonary complications after esophagectomy | Q34567293 | ||
| A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer | Q34593949 | ||
| Multimodality therapy for esophageal cancer | Q35020394 | ||
| Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality? | Q35072610 | ||
| Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer | Q35185450 | ||
| The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study. | Q35227504 | ||
| Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer | Q35663484 | ||
| Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis | Q35803550 | ||
| Reducing hospital morbidity and mortality following esophagectomy | Q35908996 | ||
| Induction therapy does not increase surgical morbidity after esophagectomy for cancer | Q35931400 | ||
| Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival | Q36076704 | ||
| Correlation Between Tumor Regression Grade and Clinicopathological Parameters in Patients With Squamous Cell Carcinoma of the Esophagus Who Received Neoadjuvant Chemoradiotherapy | Q36153225 | ||
| Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer | Q36186165 | ||
| Management of oesophageal cancer | Q36262306 | ||
| Meta-analysis in clinical trials revisited | Q36264762 | ||
| Are squamous and adenocarcinomas of the esophagus the same disease? | Q36690742 | ||
| American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma. | Q36732038 | ||
| The "number needed to treat" turns 20--and continues to be used and misused | Q36856802 | ||
| A general framework for the evaluation of clinical trial quality | Q37223882 | ||
| Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
| Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. | Q37449181 | ||
| Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma | Q37618080 | ||
| Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy | Q38100673 | ||
| Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers. | Q38184934 | ||
| Number needed to treat: a descriptor for weighing therapeutic options | Q39730677 | ||
| Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. | Q39737918 | ||
| Prognostic Impact of Postoperative Complications in 502 Patients With Surgically Resected Esophageal Squamous Cell Carcinoma: A Retrospective Single-institution Study | Q40209404 | ||
| Multimodal treatment for squamous cell esophageal cancer | Q40527896 | ||
| Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. | Q40645806 | ||
| Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists | Q40996403 | ||
| CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. | Q41366693 | ||
| Using numerical results from systematic reviews in clinical practice | Q41461392 | ||
| Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer. | Q43132946 | ||
| Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer | Q43956924 | ||
| Random-effects model for meta-analysis of clinical trials: an update | Q44449763 | ||
| A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma | Q44902232 | ||
| Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery | Q46768042 | ||
| Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters | Q47373029 | ||
| Squamous cell carcinoma and adenocarcinoma of the lower third of the esophagus and gastric cardia: similarities and differences | Q51694804 | ||
| Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy. | Q53336630 | ||
| Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma | Q56782923 | ||
| Effects of Neoadjuvant Therapy on Perioperative Morbidity in Elderly Patients Undergoing Esophagectomy for Esophageal Cancer | Q56914076 | ||
| Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer | Q57259796 | ||
| Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates | Q58890524 | ||
| P433 | issue | 11 | |
| P921 | main subject | chemoradiotherapy | Q5090613 |
| esophageal squamous cell carcinoma | Q108442577 | ||
| P304 | page(s) | 3632-3640 | |
| P577 | publication date | 2016-06-08 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis | |
| P478 | volume | 23 |
| Q58715779 | Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials |
| Q90627041 | The Influence of Age on Complications and Overall Survival After Ivor Lewis Totally Minimally Invasive Esophagectomy |
Search more.